Press release
United States Peptide Therapeutics Market with CAGR of 7.8% during 2024-2031 - Exclusive Report by DatamIntelligence
Peptide Therapeutics Market
Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/peptide-therapeutics-market?sp
United States: Recent Industry Developments
✅ In September 2025, Amgen launched a novel peptide therapeutic targeting metabolic disorders, designed for enhanced stability, bioavailability, and precision receptor modulation to improve patient outcomes.
✅ In August 2025, Eli Lilly expanded clinical trials for peptide-based therapies addressing autoimmune diseases, integrating advanced delivery systems for improved efficacy and safety.
✅ In July 2025, Moderna introduced peptide therapeutics for oncology applications, leveraging mRNA technology to stimulate targeted immune responses and enhance anti-tumor activity.
✅ In June 2025, Pfizer invested in R&D for next-generation peptide therapeutics with extended half-life and tissue-specific targeting, supporting chronic disease management and precision medicine initiatives.
Japan: Recent Industry Developments
✅ In September 2025, Takeda Pharmaceutical launched peptide therapeutics for metabolic and cardiovascular disorders, focusing on stability, targeted delivery, and patient-centric outcomes.
✅ In August 2025, Astellas Pharma expanded its peptide drug portfolio with novel formulations for autoimmune and inflammatory diseases, emphasizing enhanced safety and efficacy.
✅ In July 2025, Daiichi Sankyo introduced peptide-based oncology therapies aimed at precision immune modulation, supporting improved tumor response and patient survival.
✅ In June 2025, Chugai Pharmaceutical invested in R&D for advanced peptide therapeutics using innovative delivery platforms, targeting chronic and rare diseases in Japan.
Peptide Therapeutics Market: Drivers
The peptide therapeutics market is witnessing robust growth, driven by increasing demand for targeted and highly specific therapies across oncology, metabolic disorders, infectious diseases, and cardiovascular conditions. Peptides, due to their high specificity, low toxicity, and favorable pharmacokinetic profiles, are emerging as effective alternatives to traditional small molecules and biologics. Advances in peptide synthesis, modification technologies, and delivery systems are enhancing stability, bioavailability, and therapeutic efficacy. Growing investments in research and development, rising prevalence of chronic and rare diseases, and expanding adoption of precision medicine are further supporting market growth. Increasing regulatory approvals and awareness among healthcare providers and patients are boosting adoption of peptide-based therapies globally.
Leading pharmaceutical and biotechnology companies, including Novo Nordisk, Amgen, Pfizer, and Bachem, are actively developing innovative peptide therapeutics for diverse indications such as diabetes, cancer, and infectious diseases. Research into novel peptide conjugates, oral formulations, and long-acting delivery systems is expanding therapeutic possibilities. Strategic collaborations between biotech firms, academic institutions, and pharmaceutical companies are accelerating clinical development, regulatory approval, and commercialization of advanced peptide therapies. Rising focus on personalized medicine, patient-centric treatment approaches, and unmet medical needs is driving market adoption. With continuous innovation, increasing clinical applications, and growing healthcare awareness, the peptide therapeutics market is poised for sustained global growth.
Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/peptide-therapeutics-market?sp
Peptide Therapeutics Market: Major Players
Eli Lilly and Company, Amgen Inc., Pfizer Inc., Bristol-Myers Squibb Company, Ever Neuro Pharma GmbH, Takeda Pharmaceutical Company Limited, Teva Pharmaceuticals Industries Ltd, AstraZeneca PLC, GlaxoSmithKline PLC, and Novo Nordisk AS among others.
Segment Covered in the Peptide Therapeutics Market:
➥ By Type: Patented, Generic
➥ By Application: Cancer, Cardiovascular Diseases, Metabolic Diseases, Central Nervous System Disorders, Respiratory Diseases, Infectious Diseases
➥ By Route of Administration: Oral Route, Parenteral Route
➥ By Technology: Solid Phase Peptide Synthesis (SPPS), Liquid Phase Peptide Synthesis (LPPS), Hybrid Phase Peptide Synthesis (HPPS)
Research Process:
Both primary and secondary data sources have been used in the Peptide Therapeutics Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Most Frequently Asked Questions in the Peptide Therapeutics Market Research Industry:
➠ Who leads the Peptide Therapeutics industry and what's their competitive positioning regarding capacity, performance, and profitability?
➠ What growth opportunities and market challenges do Peptide Therapeutics market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting Peptide Therapeutics market growth?
➠ What are the dominant sales and distribution strategies in the Peptide Therapeutics industry?
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=peptide-therapeutics-market
Regional Analysis:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Peptide Therapeutics Market with CAGR of 7.8% during 2024-2031 - Exclusive Report by DatamIntelligence here
News-ID: 4227303 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
United States Artificial Intelligence in Healthcare Market to Reach USD 187.7 Bi …
Artificial Intelligence in Healthcare Market Overview
The Global Artificial Intelligence (AI) in Healthcare Market reached USD 13,248.65 million in 2022 and is projected to grow significantly, reaching USD 187,704.75 million by 2031, expanding at an impressive CAGR of 41.1% during 2024-2031. The market's rapid growth is driven by the increasing integration of AI technologies across various aspects of healthcare, from clinical diagnosis and imaging to drug discovery, patient monitoring, and hospital…
United States Smart Syringe Market 2033 | Growth Drivers, Key Players & Investme …
Market Size and Growth
Smart Syringe Market reached US$ 12.22 Billion in 2024 and is expected to reach US$ 25.97 Billion by 2033, growing at a CAGR of 8.8% during the forecast period 2025-2033.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/smart-syringe-market?sb
Key Development:
United States: Recent Industry Developments
✅ In September 2025, Apiject Systems, Corp. submitted a regulatory filing to the U.S. Food and Drug Administration…
United States Bovine Colostrum Market to Reach $5.19 Billion by 2031, Driven by …
Leander, Texas and TOKYO, Japan - Dec.10.2025
Market Size
As per DataM Intelligence research report, "The Global Bovine Colostrum Market reached US$ 3.21 billion in 2022 and is expected to reach US$ 5.19 billion by 2031, growing at a CAGR of 6.21% during the forecast period 2024-2031." Rising awareness of immune-boosting supplements and increasing demand for functional dairy products are driving market growth.
Download your exclusive sample report today: (corporate email gets priority…
United States Tungsten-Based Materials Market 2031 | Growth Drivers, Key Players …
Market Size and Growth
Global Tungsten-Based Materials Market reached US$ 5.9 billion in 2023 and is expected to reach US$ 9.4 billion by 2031, growing with a CAGR of 6.1% during the forecast period 2024-2031.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/tungsten-based-materials-market?sb
Key Development:
United States: Recent Developments
✅ In November 2025, Global Tungsten & Powders was awarded a grant by the U.S. Department of Energy…
More Releases for Peptide
ShiLai Peptide to Invest $32 Million in State-of-the-Art Peptide Laboratory in H …
ShiLai Peptide's CEO, Luo Binhua, said the investment reflects the company's commitment to a "new science model" that integrates research-driven development, controlled production, and specialized customer support.
ShiLai Peptide [https://retatrutidesupplier.com/], a leading provider of high-purity, customizable research peptides, announced plans to invest $32 million to build a state-of-the-art peptide research and production laboratory in Hangzhou. The facility is designed to meet world-class GMP standards, aiming to strengthen ShiLai's global supply of…
Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth…
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension…
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global…
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…
